https://www.selleckchem.com/pr....oducts/kartogenin.ht
The search for additional pharmacotherapeutic agents that could be used singly or in combination with hydroxyurea and/or l-glutamine awaits their dawn hopefully in the near future. The purpose of this review is to describe the various manifestations of SCD, their pathophysiology and their current management. Recent impressive advances in understanding the pathophysiology of pain promise the determination of agents that could replace or minimize the use of opioids. OBJECTIVE Sickle Cell Disease (SCD) is an inherited blood disorder tha
Like
Comment
Share
